The Q4 numbers of IPCA Labs (CMP: Rs 901; Market Cap: Rs 22,863 crore) were chiefly helped by the domestic formulations business, which constitutes 43 percent of the overall business. The domestic formulations business grew 27 percent, which was partially offset by the mediocre performance of the other segments leading to a 16 percent growth in the top line. The API business (20 percent of sales) continues to be impacted by the sales returns due to the issue of Azido impurity...
Moneycontrol Pro Panorama | Can somebody call the bottom by now?
Jun 27, 2022 / 06:35 PM IST
In today’s edition of Moneycontrol Pro Panorama: The bounce in markets, Fintech trouble, Zomato-Blinkit, IT's defensive traits and moreRead Now
MC Pro Weekender | A new narrative
Jun 25, 2022 / 12:28 PM IST
Stock markets are celebrating the turn in inflation, but the bond markets are looking at the coming slowdownRead Now
To read the full story, Subscribe to Moneycontrol PRO
Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience
Already a member? Sign in
Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to
Ad free experience
Experience a non-intrusive navigation and faster response in the ad free mode
Access to 230+ exclusive stories per month from our editorial and Experts
Have a Global edge with access to content from world renowned experts and journalist
Access to 40+ weekly investment ideas including 4 daily technical calls
Exclusive access to live webinars from market experts on trading and investment strategies
Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.
Get upto 50% discount on limited period offers